Last Updated: September 29, 2026

INZIRQO Drug Patent Profile

Name: INZIRQO Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Inzirqo, and what generic alternatives are available?

Inzirqo is a drug marketed by Novitium Pharma and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in INZIRQO is hydrochlorothiazide. There is one drug master file entry for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Inzirqo

A generic version of INZIRQO was approved as hydrochlorothiazide by UNICHEM on August 15^th, 2008.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for INZIRQO?
What are the global sales for INZIRQO?
What is Average Wholesale Price for INZIRQO?

Summary for INZIRQO

US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Patent Applications:	4,614
Drug Prices:	Drug price information for INZIRQO
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for INZIRQO
What excipients (inactive ingredients) are in INZIRQO?	INZIRQO excipients list
DailyMed Link:	INZIRQO at DailyMed

Drug patent expirations by year for INZIRQO

Pharmacology for INZIRQO

Drug Class	Thiazide Diuretic
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for INZIRQO

INZIRQO is protected by two US patents.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novitium Pharma	INZIRQO	hydrochlorothiazide	FOR SUSPENSION;ORAL	219141-001	Jan 28, 2025		RX	Yes	Yes	11,878,022	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.